June 5, 2022
Sanoff offers perspective on a promising rectal cancer study in the New England Journal of Medicine
Hanna K. Sanoff, MD, MPH, is the author of a viewpoint that provides a perspective on the evolving treatment of rectal cancer in light of findings from a phase II clinical trial using the drug dostarlimab.